Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MTOR | P42345 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KLK7 | P49862 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8101940 | 0.91 | NPY5R (0.44) | MEN1KMT2ANPSR1NPY5RNPC1 | |
| SCHEMBL7608699 | 0.91 | MEN1 (0.49) | MEN1KMT2AMTORALDH1A1NPSR1 | |
| SCHEMBL7612777 | 0.91 | SLC1A3 (0.49) | MEN1KMT2AALDH1A1NPY5RKDM4E | |
| SCHEMBL7615446 | 0.88 | SLC1A3 (0.51) | MEN1KMT2AMTORALDH1A1NPSR1 | |
| SCHEMBL7615411 | 0.88 | SMN1; SMN2 (0.61) | MEN1KMT2AALDH1A1NPSR1NPY5R | |
| SCHEMBL7613037 | 0.88 | NPY5R (0.65) | ALDH1A1NPY5RNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7610023 | 0.87 | MEN1 (0.51) | MEN1KMT2AMTORALDH1A1NPSR1 | |
| SCHEMBL7611785 | 0.85 | NPY5R (0.57) | MEN1KMT2AMTORALDH1A1NPSR1 | |
| SCHEMBL7612429 | 0.84 | MITF (0.56) | MEN1KMT2AALDH1A1NPY5RNPC1 | |
| SCHEMBL8103580 | 0.83 | NPY5R (0.56) | ALDH1A1NPY5RL3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1699847-B1 | METHOD FOR THE PREPARATION OF MEDICINAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES CO (US) | 2011-04-13 | — | — | EP | claimed |
| US-7687054-B2 | Biocompatible compounds for sustained release pharmaceutical drug delivery systems | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-30 | — | — | US | claimed |
| US-7597897-B2 | Medicinal compositions and method for the preparation thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-10-06 | — | — | US | claimed |
| US-20080267885-A1 | Medicinal Compositions and Method for the Preparation Thereof | 3M INNOVATIVE PROPERTIES COMPANY | 2008-10-30 | — | — | US | claimed |
| EP-1815845-A2 | Biocompatible compounds for pharmaceutical drug delivery systems | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2007-08-08 | — | — | EP | claimed |
| EP-1014944-B1 | BIOCOMPATIBLE COMPOUNDS FOR PHARMACEUTICAL DRUG DELIVERY SYSTEMS | MINNESOTA MINING & MFG (US) | 2007-04-11 | — | — | EP | claimed |
| CN-1902254-A | Medicinal compositions and method for the preparation thereof | 3M INNOVATIVE PROPERTIES CO (US) | 2007-01-24 | — | — | CN | claimed |
| EP-1699847-A1 | MEDICINAL COMPOSITIONS AND METHOD FOR THE PREPARATION THEREOF | 3M Innovative Properties Company (US) | 2006-09-13 | — | — | EP | claimed |
| US-20060002995-A1 | Pharmaceutical porous particles | ADAGIT (SE) | 2006-01-05 | — | — | US | claimed |
| EP-1569626-A1 | PHARMACEUTICAL POROUS PARTICLES | Adagit (SE) | 2005-09-07 | — | — | EP | claimed |
| EP-0777471-B1 | INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH UREA DERIVATIVES | MINNESOTA MINING & MFG (US) | 2002-11-27 | — | — | EP | claimed |
| US-20020164290-A1 | Biocompatible compounds for sustained release pharmaceutical drug delivery systems | 3M INNOVATIVE PROPERTIES COMPANY | 2002-11-07 | — | — | US | claimed |
| US-6416742-B1 | DISSOLVED POLYLACTONE, POLYTHIOESTER, OR POLYLACTAM AND FLUOROCARBON PROPELLANT; BIODEGRADABLE POLYMER STABILIZES AND SOLUBILIZES THE DRUG; SUSTAINED RELEASE | 3M INNOVATIVE PROPERTIES COMPANY | 2002-07-09 | — | — | US | claimed |
| US-6126919-A | METERED DOSE INHALER FOR SUSTAINED RELEASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| EP-1014944-A2 | BIOCOMPATIBLE COMPOUNDS FOR PHARMACEUTICAL DRUG DELIVERY SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-07-05 | — | — | EP | claimed |
| CN-1246790-A | Biocompatible compounds for pharmaceutical drug delivery systems | MINNESOTA MINING & MFG (US) | 2000-03-08 | — | — | CN | claimed |
| WO-1998034596-A2 | BIOCOMPATIBLE COMPOUNDS FOR PHARMACEUTICAL DRUG DELIVERY SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-08-13 | — | — | WO | claimed |
| EP-0777471-A1 | INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH UREA DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-06-11 | — | — | EP | claimed |
| US-5612377-A | OXYUREA DERIVATIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-03-18 | — | — | US | claimed |
| WO-1996003983-A1 | INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH UREA DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-02-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080267885-A1 | Medicinal Compositions and Method for the Preparation Thereof | CA7, ADCY1, CA12 | MEN1 1139/4885KMT2A 3330/4885MTOR 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.